Northern Trust
KURA icon

Northern Trust’s Kura Oncology KURA Stock Holding History

Northern Trust’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12M Buy
831,160
+74,887
+10% +$707K ﹤0.01% 2271
2026
Q1 		$6.15M Buy
756,273
+33,056
+5% +$284K ﹤0.01% 2352
2025
Q4 		$7.51M Sell
723,217
-30,383
-4% -$319K ﹤0.01% 2234
2025
Q3 		$6.67M Buy
753,600
+59,790
+9% +$426K ﹤0.01% 2330
2025
Q2 		$4M Buy
693,810
+12,180
+2% +$74.6K ﹤0.01% 2586
2025
Q1 		$4.5M Buy
681,630
+16,702
+3% +$130K ﹤0.01% 2478
2024
Q4 		$5.79M Sell
664,928
-20,239
-3% -$291K ﹤0.01% 2421
2024
Q3 		$13.4M Buy
685,167
+21,546
+3% +$437K ﹤0.01% 1891
2024
Q2 		$13.7M Sell
663,621
-30,725
-4% -$632K ﹤0.01% 1813
2024
Q1 		$14.8M Sell
694,346
-15,474
-2% -$301K ﹤0.01% 1808
2023
Q4 		$10.2M Buy
709,820
+4,442
+0.6% +$43.7K ﹤0.01% 2057
2023
Q3 		$6.43M Buy
705,378
+78,492
+13% +$797K ﹤0.01% 2283
2023
Q2 		$6.63M Sell
626,886
-6,316
-1% -$74.7K ﹤0.01% 2341
2023
Q1 		$7.74M Sell
633,202
-128,032
-17% -$1.6M ﹤0.01% 2193
2022
Q4 		$9.45M Buy
761,234
+124,422
+20% +$1.81M ﹤0.01% 2051
2022
Q3 		$8.7M Buy
636,812
+3,030
+0.5% +$46.7K ﹤0.01% 2078
2022
Q2 		$11.6M Sell
633,782
-19,766
-3% -$284K ﹤0.01% 1913
2022
Q1 		$10.5M Sell
653,548
-7,313
-1% -$106K ﹤0.01% 2114
2021
Q4 		$9.25M Sell
660,861
-88,673
-12% -$1.44M ﹤0.01% 2286
2021
Q3 		$14M Sell
749,534
-15,645
-2% -$295K ﹤0.01% 2045
2021
Q2 		$16M Buy
765,179
+48,766
+7% +$1.21M ﹤0.01% 2049
2021
Q1 		$20.3M Sell
716,413
-34,850
-5% -$1.1M ﹤0.01% 1816
2020
Q4 		$24.5M Buy
751,263
+75,088
+11% +$2.64M ﹤0.01% 1648
2020
Q3 		$20.7M Sell
676,175
-24,742
-4% -$546K ﹤0.01% 1600
2020
Q2 		$11.4M Buy
700,917
+244,302
+54% +$3.52M ﹤0.01% 2017
2020
Q1 		$4.54M Buy
456,615
+23,635
+5% +$271K ﹤0.01% 2361
2019
Q4 		$5.95M Sell
432,980
-32,635
-7% -$484K ﹤0.01% 2486
2019
Q3 		$7.06M Buy
465,615
+80,137
+21% +$1.43M ﹤0.01% 2361
2019
Q2 		$7.59M Buy
385,478
+7,249
+2% +$120K ﹤0.01% 2320
2019
Q1 		$6.28M Buy
378,229
+2,974
+0.8% +$45.8K ﹤0.01% 2431
2018
Q4 		$5.27M Sell
375,255
-2,062
-0.5% -$27.3K ﹤0.01% 2471
2018
Q3 		$6.6M Buy
377,317
+57,897
+18% +$1.11M ﹤0.01% 2524
2018
Q2 		$5.81M Buy
319,420
+63,912
+25% +$1.08M ﹤0.01% 2612
2018
Q1 		$4.79M Buy
255,508
+20,961
+9% +$408K ﹤0.01% 2613
2017
Q4 		$3.59M Buy
234,547
+24,668
+12% +$364K ﹤0.01% 2809
2017
Q3 		$3.14M Buy
209,879
+62,396
+42% +$586K ﹤0.01% 2908
2017
Q2 		$1.37M Buy
147,483
+133,293
+939% +$1.21M ﹤0.01% 3355
2017
Q1 		$125K Buy
14,190
+1,808
+15% +$13.3K ﹤0.01% 3908
2016
Q4 		$73K Buy
12,382
+1,495
+14% +$8.02K ﹤0.01% 3961
2016
Q3 		$68K Buy
+10,887
New +$55.2K ﹤0.01% 3960

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Northern Trust's KURA Position: Q2 2026 in Review

Northern Trust increased its Kura Oncology (KURA) stake by 9.9% in Q2 2026, buying an estimated $707K and bringing the position to 831,160 shares worth $9.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

Northern Trust first reported a position in KURA in Q3 2016 and has held it in 40 quarters since. The position peaked at $24.5M in Q4 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Northern Trust held 831,160 shares of Kura Oncology worth $9.12M as of Q2 2026.
  • Northern Trust bought 74,887 Kura Oncology shares in Q2 2026, an estimated $707K.
  • Kura Oncology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2271 holding.
  • Northern Trust first reported a position in Kura Oncology in Q3 2016 and has held it in 40 quarters since.
  • Northern Trust's Kura Oncology position peaked at $24.5M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.